Study gut bacteria and gut chemistry after gallbladder treatment
Part of Digestive system clinical trials.
This study looks at how your gut bacteria and gut chemical products change after treatment for gallstones. It may help researchers understand what drives symptoms and recovery after surgery and/or endoscopic procedures.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 21 and 80 years old
- You have symptomatic gallstone disease, confirmed by imaging tests like ultrasound, CT, MRI, or endoscopic ultrasound
- You are scheduled to have your gallbladder removed (cholecystectomy), with or without an ERCP procedure for bile duct stones
- You are willing to sign a consent form and join the study
- In the last month, you have not taken antibiotics or probiotics (except antibiotics within 48 hours around surgery/ERCP)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial is studying people with gallbladder cancer, abnormal cell changes (dysplasia), or gallstones. It aims to learn more about these conditions, possibly before or after treatment, or before gallbladder removal surgery.
This study looks at gut bacteria (your microbiome) in people with gallstones to better understand what’s going on in the body. It includes adults having gallbladder removal surgery, and it may help researchers find better ways to predict or treat gallstone disease.
This study looks at how a common bowel prep medicine (PEG laxatives) affects gut bacteria in people who have had their gallbladder removed compared to those who still have one. It involves collecting stool samples before and after a colonoscopy to track changes over time.
This study is testing a tool to predict survival after gallbladder removal for people with acute cholecystitis caused by gallstones. By joining, you help doctors better assess risk and improve care for future patients.
This trial compares two minimally invasive treatments for people with severe gallbladder inflammation caused by gallstones. It aims to see which approach better helps the immune system and reduces risks for those who are too sick for standard surgery.
This study looks at patients with uncomplicated gallstones who are scheduled for gallbladder removal surgery. It aims to improve care by comparing different approaches to managing your stones before surgery.
Hear when a new Gallstone Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.